BLCO · CIK 0001860742 · FY2025 live · 2025-12-31
Bausch & Lomb Corp
View as
Model
Classic Z
FY2025
0.90
Zone
Distress
Prior
—
Market DD
—
1y PD
—
0.90
Z″ 1.23
Score 0.90 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.081.2 × = 0.09X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−0.071.4 × = −0.09X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
0.013.3 × = 0.03X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
0.860.6 × = 0.52X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.361 × = 0.36
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings.
Meridian Rank
52.09
0–100 · Classic Z family
Book standing
45
Year change
—
Market PD
—
O-score
71
Events on this name
Same published rows as Today.
No published events on this print.
Overview
rule-v1
Bausch & Lomb Corp is on classic Z at 0.90 (distress) for FY2025, from an SEC 10-K. Book equity / liabilities is the line that sets the print; sales / assets is the runner-up. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers. Buybacks can send retained earnings negative at otherwise healthy issuers. X4 is book equity.
Book screen Distress; market PD —. Market PD has not been priced on this name.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 66th percentile in Healthcare.
- EVAXDistressEvaxion A/S0.90
- JAZZDistressJazz Pharmaceuticals plc0.87
- ELANDistressElanco Animal Health Inc0.87
- KRMDDistressKORU Medical Systems, Inc.0.94
- ZYBTDistressZhengye Biotechnology Holding Ltd0.87
- DYNDistressDyne Therapeutics, Inc.0.85
- BVSDistressBioventus Inc.0.85
- RIGLDistressRIGEL PHARMACEUTICALS INC0.84
Filing line items
Current assets
$3.0B
Total assets
$14.0B
Current liabilities
$1.9B
Total liabilities
$7.5B
Working capital
$1.1B
Retained earnings
−$931M
EBIT
$113M
Total sales
$5.1B
Book equity
$6.4B
Accession 0001860742-26-000007. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as is a display overlay. X4 is book equity. Pulled 13 Sept 2026.